F2 and pertussis: Around 80–85% of individuals develop antibodies to the pertussis toxin (PT) at concentrations >100 UI/ml following pertussis infection; around 78% do so following vaccine with the whole-cell pertussis vaccine (our focus here), although this shows considerable variability [6].